| 1 |
35485096 | Preventive effect of salicin ether against type-2 diabetes mellitus through targeting PPARγ-regulated gene expression. | 2022 Apr 28 |
1 |
| 2 |
33115283 | Combination treatment strategies with a focus on rosiglitazone and adriamycin for insulin resistant liver cancer. | 2021 Mar |
1 |
| 3 |
33843164 | Silencing of DsbA-L gene impairs the PPARγ agonist function of improving insulin resistance in a high-glucose cell model. | 2020 Dec. |
2 |
| 4 |
31276504 | Rosiglitazone in the thawing medium improves mitochondrial function in stallion spermatozoa through regulating Akt phosphorylation and reduction of caspase 3. | 2019 |
2 |
| 5 |
26048716 | Rosiglitazone suppresses HIV-1 Tat-induced vascular inflammation via Akt signaling. | 2015 Sep |
1 |
| 6 |
24491054 | [Rosiglitazone inhibits human HepG2 cell proliferation via PI3K/PTEN/Akt signaling pathway]. | 2014 Feb |
2 |
| 7 |
24787994 | Peroxisome proliferator-activated receptor γ ligands inhibit VEGF-mediated vasculogenic mimicry of prostate cancer through the AKT signaling pathway. | 2014 Jul |
1 |
| 8 |
24032744 | Targeting the ABCG2-overexpressing multidrug resistant (MDR) cancer cells by PPARγ agonists. | 2013 Nov |
1 |
| 9 |
22050182 | Anti-proliferative effect of rosiglitazone on angiotensin II-induced vascular smooth muscle cell proliferation is mediated by the mTOR pathway. | 2012 Mar 1 |
1 |
| 10 |
22659796 | Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells. | 2012 Jun 15 |
1 |
| 11 |
20455996 | The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth. | 2011 Apr |
1 |
| 12 |
21333731 | Double antioxidant activities of rosiglitazone against high glucose-induced oxidative stress in hepatocyte. | 2011 Jun |
1 |
| 13 |
19732122 | The PPAR-gamma agonist rosiglitazone facilitates Akt rephosphorylation and inhibits apoptosis in cardiomyocytes during hypoxia/reoxygenation. | 2009 Nov |
1 |
| 14 |
19767878 | Rosiglitazone inhibits high glucose-induced apoptosis in human umbilical vein endothelial cells through the PI3K/Akt/eNOS pathway. | 2009 Jul |
4 |
| 15 |
19917066 | Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products. | 2009 Dec |
3 |
| 16 |
18475308 | Rosiglitazone attenuates insulin-like growth factor 1 receptor survival signaling in PC-3 cells. | 2008 Jul-Aug |
2 |
| 17 |
18606715 | A novel combination: ranpirnase and rosiglitazone induce a synergistic apoptotic effect by down-regulating Fra-1 and Survivin in cancer cells. | 2008 Jul |
1 |
| 18 |
16505118 | Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways. | 2006 Feb |
3 |
| 19 |
16775433 | PPARgamma activator rosiglitazone inhibits cell migration via upregulation of PTEN in human hepatocarcinoma cell line BEL-7404. | 2006 Aug |
1 |
| 20 |
16777971 | Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells. | 2006 Sep |
1 |
| 21 |
15950942 | The PPAR-gamma activator, Rosiglitazone, inhibits actin polymerisation in monocytes: involvement of Akt and intracellular calcium. | 2005 Jul 29 |
2 |
| 22 |
16204373 | Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3'-kinase-dependent pathway. | 2005 Dec |
1 |